Ernexa Reports Positive ERNA-101 Safety Data Ahead Of Q4 IND
(RTTNews) - Wednesday, Ernexa Therapeutics (ERNA) reported positive results from three IND-enabling safety studies of ERNA-101, its investigational iMSC therapy for advanced cancers.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
